Regulation of phosphatidylethanolamine homeostasis-the critical role of CTP: Phosphoethanolamine cytidylyltransferase (Pcyt2)

International Journal of Molecular Sciences

Volumn 14, Issue 2, 2013, Pages 2529-2550

  Pavlovic, Zvezdan ^a   Bakovic, Marica ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cell growth; CTP:phosphoethanolamine cytidylyltransferase; Hypertriglyceridemia; Insulin resistance; Lipid homeostasis; Liver steatosis; Metabolic syndrome; Obesity; Pcyt2; Phosphatidylethanolamine

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE TRIPHOSPHATE CITRATE LYASE; CHOLINE; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; CHOLINEPHOSPHOTRANSFERASE; DIACYLGLYCEROL; ETHANOLAMINE; FATTY ACID SYNTHASE; HISTONE DEACETYLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPOPROTEIN; LIVER X RECEPTOR; METHOTREXATE; PHOSPHATIDYLETHANOLAMINE; REACTIVE OXYGEN METABOLITE; STEROL REGULATORY ELEMENT BINDING PROTEIN;

APOPTOSIS; AUTOPHAGY; CANCER GROWTH; CELL CYCLE REGULATION; CELL GROWTH; EMBRYO DEVELOPMENT; FATTY LIVER; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOGENESIS; LIPOPROTEIN SECRETION; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; REVIEW;

EID: 84875114132     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14022529     Document Type: Review

References (89)

1. Deeba, F.; Tahseen, H.N.; Sharad, K.S.; Ahmad, N.; Akhtar, S.; Saleemuddin, M.; Mohammad, O. Phospholipid diversity: Correlation with membrane-membrane fusion events. Biochim. Biophys. Acta 2005, 1669, 170-181.
2. Emoto, K.; Kobayashi, T.; Yamaji, A.; Aizawa, H.; Yahara, I.; Inoue, K.; Umeda, M. Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proc. Natl. Acad. Sci. USA 1996, 93, 12867-12872.
3. Ichimura, Y.; Kirisako, T.; Takao, T.; Satomi, Y.; Shimonishi, Y.; Ishihara, N.; Mizushima, N.; Tanida, I.; Kominami, E.; Ohsumi, M.; et al. A ubiquitin-like system mediates protein lipidation. Nature 2000, 408, 488-492.
4. Emoto, K.; Toyama-Sorimachi, N.; Karasuyama, H.; Inoue, K.; Umeda, M. Exposure of phosphatidylethanolamine on the surface of apoptotic cells. Exp. Cell Res. 1997, 232, 430-434.
5. Vance, J.E.; Tasseva, G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim. Biophys. Acta 2012, in press.
6. Gibellini, F.; Smith, T.K. The Kennedy pathway-de novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 2010, 62, 414-428.
7. Sundler, R. Ethanolaminephosphate cytidylyltransferase. Purification and characterization of the enzyme from rat liver. J. Biol. Chem. 1975, 250, 8585-8590.
8. Bladergroen, B.A.; van Golde, L.M. CTP:Phosphoethanolamine cytidylyltransferase. Biochim. Biophys. Acta 1997, 1348, 91-99.
9. Ross, B.M.; Moszczynska, A.; Blusztajn, J.K.; Sherwin, A.; Lozano, A.; Kish, S.J. Phospholipid biosynthetic enzymes in human brain. Lipids 1997, 32, 351-358.
10. Vermeulen, P.S.; Geelen, M.J.; van Golde, L.M. Substrate specificity of CTP: phosphoethanolamine cytidylyltransferase purified from rat liver. Biochim. Biophys. Acta 1994, 1211, 343-349.
11. Vermeulen, P.S.; Tijburg, L.B.; Geelen, M.J.; van Golde, L.M. Immunological characterization, lipid dependence, and subcellular localization of CTP:phosphoethanolamine cytidylyltransferase purified from rat liver. comparison with CTP:phosphocholine cytidylyltransferase. J. Biol. Chem. 1993, 268, 7458-7464.
12. Houweling, M.; Tijburg, L.B.; Vaartjes, W.J.; van Golde, L.M. Phosphatidylethanolamine metabolism in rat liver after partial hepatectomy. control of biosynthesis of phosphatidylethanolamine by the availability of ethanolamine. Biochem. J. 1992, 283, 55-61.
13. Tijburg, L.B.; Vermeulen, P.S.; Schmitz, M.G.; van Golde, L.M. Okadaic acid inhibits phosphatidylethanolamine biosynthesis in rat hepatocytes. Biochem. Biophys. Res. Commun. 1992, 182, 1226-1231.
14. Tijburg, L.B.; Houweling, M.; Geelen, J.H.; van Golde, L.M. Stimulation of phosphatidylethanolamine synthesis in isolated rat hepatocytes by phorbol 12-myristate 13-acetate. Biochim. Biophys. Acta 1987, 922, 184-190.
15. Bleijerveld, O.B.; Klein, W.; Vaandrager, A.B.; Helms, J.B.; Houweling, M. Control of the CDPethanolamine pathway in mammalian cells: Effect of ctp:phosphoethanolamine cytidylyltransferase overexpression and the amount of intracellular diacylglycerol. Biochem. J. 2004, 379, 711-719.
16. Tijburg, L.B.; Schuurmans, E.A.; Geelen, M.J.; van Golde, L.M. Effects of vasopressin on the synthesis of phosphatidylethanolamines and phosphatidylcholines by isolated rat hepatocytes. Biochim. Biophys. Acta 1987, 919, 49-57.
17. Van Hellemond, J.J.; Slot, J.W.; Geelen, M.J.; van Golde, L.M.; Vermeulen, P.S. Ultrastructural localization of CTP:phosphoethanolamine cytidylyltransferase in rat liver. J. Biol. Chem. 1994, 269, 15415-15418.
18. Dechamps, S.; Wengelnik, K.; Berry-Sterkers, L.; Cerdan, R.; Vial, H.J.; Gannoun-Zaki, L. The Kennedy phospholipid biosynthesis pathways are refractory to genetic disruption in plasmodium berghei and therefore appear essential in blood stages. Mol. Biochem. Parasitol. 2010, 173, 69-80.
19. Bladergroen, B.A.; Geelen, M.J.; Reddy, A.C.; Declercq, P.E.; van Golde, L.M. Channelling of intermediates in the biosynthesis of phosphatidylcholine and phosphatidylethanolamine in mammalian cells. Biochem. J. 1998, 334, 511-517.
20. Min-Seok, R.; Kawamata, Y.; Nakamura, H.; Ohta, A.; Takagi, M. Isolation and characterization of ECT1 gene encoding CTP: phosphoethanolamine cytidylyltransferase of Saccharomyces cerevisiae. J. Biochem. 1996, 120, 1040-1047.
21. Nakashima, A.; Hosaka, K.; Nikawa, J. Cloning of a human cDNA for CTP-phosphoethanolamine cytidylyltransferase by complementation in vivo of a yeast mutant. J. Biol. Chem. 1997, 272, 9567-9572.
22. Bladergroen, B.A.; Houweling, M.; Geelen, M.J.; van Golde, L.M. Cloning and expression of CTP:phosphoethanolamine cytidylyltransferase cDNA from rat liver. Biochem. J. 1999, 343, 107-114.
23. Poloumienko, A.; Cote, A.; Quee, A.T.; Zhu, L.; Bakovic, M. Genomic organization and differential splicing of the mouse and human Pcyt2 genes. Gene 2004, 325, 145-155.
24. Marchler-Bauer, A.; Lu, S.; Anderson, J.B.; Chitsaz, F.; Derbyshire, M.K.; DeWeese-Scott, C.; Fong, J.H.; Geer, L.Y.; Geer, R.C.; Gonzales, N.R.; et al. CDD: A conserved domain database for the functional annotation of proteins. Nucleic Acids Res. 2011, 39, D225-D229.
25. Tie, A.; Bakovic, M. Alternative splicing of CTP:phosphoethanolamine cytidylyltransferase produces two isoforms that differ in catalytic properties. J. Lipid Res. 2007, 48, 2172-2181.
26. Zhu, L.; Bakovic, M. Breast cancer cells adapt to metabolic stress by increasing ethanolamine phospholipid synthesis and CTP:ethanolaminephosphate cytidylyltransferase-Pcyt2 activity. Biochem. Cell Biol. 2012, 90, 188-199.
27. Expasy-Swiss Institute of Biotechnology Bioinformatics Resource Portal. Available online: http://www.expacy.org/ (accessed on 1 October 2012).
28. Johnson, C.M.; Yuan, Z.; Bakovic, M. Characterization of transcription factors and cis-acting elements that regulate human CTP: phosphoethanolamine cytidylyltransferase (Pcyt2). Biochim. Biophys. Acta 2005, 1735, 230-235.
29. Zhu, L.; Johnson, C.; Bakovic, M. Stimulation of the human CTP:phosphoethanolamine cytidylyltransferase gene by early growth response protein 1. J. Lipid Res. 2008, 49, 2197-2211.
30. Zhu, L.; Michel, V.; Bakovic, M. Regulation of the mouse CTP: Phosphoethanolamine cytidylyltransferase gene Pcyt2 during myogenesis. Gene 2009, 447, 51-59.
31. Zhu, L.; Bakovic, M. Liver X receptor agonists inhibit the phospholipid regulatory gene CTP: Phosphoethanolamine cytidylyltransferase-Pcyt2. Res. Lett. Biochem. 2008, 2008, 801849.1-801849.5.
32. Ando, H.; Horibata, Y.; Yamashita, S.; Oyama, T.; Sugimoto, H. Low-density lipoprotein and oxysterols suppress the transcription of CTP: Phosphoethanolamine cytidylyltransferase in vitro. Biochim. Biophys. Acta 2010, 1801, 487-495.
33. Shan, L.; Chen, Y.A.; Davis, L.; Han, G.; Zhu, W.; Molina, A.D.; Arango, H.; Lapolla, J.P.; Hoffman, M.S.; Sellers, T.; et al. Measurement of phospholipids may improve diagnostic accuracy in ovarian cancer. PLoS One 2012, 7, e46846.
34. Bakovic, M.; Fullerton, M.D.; Michel, V. Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis: The role of CTP:Phosphoethanolamine cytidylyltransferase (Pcyt2). Biochem. Cell Biol. 2007, 85, 283-300.
35. Vink, S.R.; van Blitterswijk, W.J.; Schellens, J.H.; Verheij, M. Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy. Cancer Treat. Rev. 2007, 33, 191-202.
36. Reddy, J.K.; Azarnoff, D.L.; Hignite, C.E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 1980, 283, 397-398.
37. Mizuguchi, H.; Kudo, N.; Ohya, T.; Kawashima, Y. Effects of tiadenol and di-(2-ethylhexyl)phthalate on the metabolism of phosphatidylcholine and phosphatidylethanolamine in the liver of rats: Comparison with clofibric acid. Biochem. Pharmacol. 1999, 57, 869-876.
38. Kudo, N.; Mizuguchi, H.; Yamamoto, A.; Kawashima, Y. Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver. Chem. Biol. Interact. 1999, 118, 69-83.
39. Boggs, K.P.; Rock, C.O.; Jackowski, S. Lysophosphatidylcholine and 1-O-octadecyl-2-O-methylrac-glycero-3-phosphocholine inhibit the CDP-choline pathway of phosphatidylcholine synthesis at the ctp:phosphocholine cytidylyltransferase step. J. Biol. Chem. 1995, 270, 7757-7764.
40. Jimenez-Lopez, J.M.; Carrasco, M.P.; Segovia, J.L.; Marco, C. Hexadecylphosphocholine inhibits phosphatidylcholine synthesis via both the methylation of phosphatidylethanolamine and CDP-choline pathways in HepG2 cells. Int. J. Biochem. Cell Biol. 2004, 36, 153-161.
41. Zhou, X.; Arthur, G. Effect of 1-O-octadecyl-2-O-methyl-glycerophosphocholine on phosphatidylcholine and phosphatidylethanolamine synthesis in MCF-7 and A549 cells and its relationship to inhibition of cell proliferation. Eur. J. Biochem. 1995, 232, 881-888.
42. Bhoumik, A.; Fichtman, B.; Derossi, C.; Breitwieser, W.; Kluger, H.M.; Davis, S.; Subtil, A.; Meltzer, P.; Krajewski, S.; Jones, N.; et al. Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc. Natl. Acad. Sci. USA 2008, 105, 1674-1679.
43. Provenzani, A.; Fronza, R.; Loreni, F.; Pascale, A.; Amadio, M.; Quattrone, A. Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. Carcinogenesis 2006, 27, 1323-1333.
44. Kim, B.C.; Shin, A.; Hong, C.W.; Sohn, D.K.; Han, K.S.; Ryu, K.H.; Park, B.J.; Nam, J.H.; Park, J.W.; Chang, H.J.; et al. Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control 2012, 23, 727-735.
45. Selga, E.; Morales, C.; Noe, V.; Peinado, M.A.; Ciudad, C.J. Role of Caveolin 1, E-Cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells. BMC Med. Genomics 2008, 1, 35.
46. Selga, E.; Oleaga, C.; Ramirez, S.; de Almagro, M.C.; Noe, V.; Ciudad, C.J. Networking of differentially expressed genes in human cancer cells resistant to methotrexate. Genome Med. 2009, 1, 83.1-83.16.
47. Crunkhorn, S.; Dearie, F.; Mantzoros, C.; Gami, H.; da Silva, W.S.; Espinoza, D.; Faucette, R.; Barry, K.; Bianco, A.C.; Patti, M.E. Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: Potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 2007, 282, 15439-15450.
48. Yamawaki, H.; Iwai, N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am. J. Physiol. Cell. Physiol. 2006, 290, C1495-C1502.
49. Yang, X.; Pratley, R.E.; Tokraks, S.; Bogardus, C.; Permana, P.A. Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant pima indians. Diabetologia 2002, 45, 1584-1593.
50. Purushotham, A.; Schug, T.T.; Xu, Q.; Surapureddi, S.; Guo, X.; Li, X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009, 9, 327-338.
51. Seale, P.; Kajimura, S.; Yang, W.; Chin, S.; Rohas, L.M.; Uldry, M.; Tavernier, G.; Langin, D.; Spiegelman, B.M. Transcriptional control of brown fat determination by PRDM16. Cell Metab. 2007, 6, 38-54.
52. Granneman, J.G.; Li, P.; Zhu, Z.; Lu, Y. Metabolic and cellular plasticity in white adipose tissue I: Effects of β3-adrenergic receptor activation. Am. J. Physiol. Endocrinol. Metab. 2005, 289, E608-E616.
53. Koza, R.A.; Nikonova, L.; Hogan, J.; Rim, J.S.; Mendoza, T.; Faulk, C.; Skaf, J.; Kozak, L.P. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet. 2006, 2, e81.
54. De Wit, N.J.; Bosch-Vermeulen, H.; de Groot, P.J.; Hooiveld, G.J.; Bromhaar, M.M.; Jansen, J.; Muller, M.; van der Meer, R. The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Med. Genomics 2008, 1, 1-14.
55. Li, H.; Xie, Z.; Lin, J.; Song, H.; Wang, Q.; Wang, K.; Su, M.; Qiu, Y.; Zhao, T.; Song, K.; et al. Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet. J. Proteome Res. 2008, 7, 4775-4783.
56. Bektas, M.; Allende, M.L.; Lee, B.G.; Chen, W.; Amar, M.J.; Remaley, A.T.; Saba, J.D.; Proia, R.L. Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver. J. Biol. Chem. 2010, 285, 10880-10889.
57. Huster, D.; Purnat, T.D.; Burkhead, J.L.; Ralle, M.; Fiehn, O.; Stuckert, F.; Olson, N.E.; Teupser, D.; Lutsenko, S. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of wilson disease. J. Biol. Chem. 2007, 282, 8343-8355.
58. Tanaka, T.; Kono, T.; Terasaki, F.; Yasui, K.; Soyama, A.; Otsuka, K.; Fujita, S.; Yamane, K.; Manabe, M.; Usui, K.; et al. Thiamine prevents obesity and obesity-associated metabolic disorders in OLETF rats. J. Nutr. Sci. Vitaminol. (Tokyo) 2010, 56, 335-346.
59. Signorell, A.; Jelk, J.; Rauch, M.; Butikofer, P. Phosphatidylethanolamine is the precursor of the ethanolamine phosphoglycerol moiety bound to eukaryotic elongation Factor 1A. J. Biol. Chem. 2008, 283, 20320-20329.
60. Gibellini, F.; Hunter, W.N.; Smith, T.K. The ethanolamine branch of the kennedy pathway is essential in the bloodstream form of Trypanosoma brucei. Mol. Microbiol. 2009, 73, 826-843.
61. Signorell, A.; Gluenz, E.; Rettig, J.; Schneider, A.; Shaw, M.K.; Gull, K.; Butikofer, P. Perturbation of phosphatidylethanolamine synthesis affects mitochondrial morphology and cell-cycle progression in procyclic-form Trypanosoma brucei. Mol. Microbiol. 2009, 72, 1068-1079.
62. Girardi, J.P.; Pereira, L.; Bakovic, M. De novo synthesis of phospholipids is coupled with autophagosome formation. Med. Hypotheses 2011, 77, 1083-1087.
63. Pereira, L.; Girardi, J.P.; Bakovic, M. Forms, crosstalks, and the role of phospholipid biosynthesis in autophagy. Int. J. Cell. Biol. 2012, 2012, 931956.1-931956.10.
64. Bakovic, M. University of Guelph, Guelph, ON, Canada. Unpublished work, 2012.
65. Deleault, N.R.; Piro, J.R.; Walsh, D.J.; Wang, F.; Ma, J.; Geoghegan, J.C.; Supattapone, S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc. Natl. Acad. Sci. USA 2012, 109, 8546-8551.
66. Li, H.; Liu, Y.; Shin, S.; Sun, Y.; Loring, J.F.; Mattson, M.P.; Rao, M.S.; Zhan, M. Transcriptome coexpression map of human embryonic stem cells. BMC Genomics 2006, 7, 103.1-103.15.
67. Giritharan, G.; Li, M.W.; de Sebastiano, F.; Esteban, F.J.; Horcajadas, J.A.; Lloyd, K.C.; Donjacour, A.; Maltepe, E.; Rinaudo, P.F. Effect of ICSI on gene expression and development of mouse preimplantation embryos. Hum. Reprod. 2010, 25, 3012-3024.
68. Swiss, V.A.; Nguyen, T.; Dugas, J.; Ibrahim, A.; Barres, B.; Androulakis, I.P.; Casaccia, P. Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation. PLoS One 2011, 6, e18088.
69. Mizoi, J.; Nakamura, M.; Nishida, I. Defects in CTP:phosphorylethanolamine cytidylyltransferase affect embryonic and postembryonic development in arabidopsis. Plant Cell 2006, 18, 3370-3385.
70. Fullerton, M.D.; Hakimuddin, F.; Bakovic, M. Developmental and metabolic effects of disruption of the mouse CTP:phosphoethanolamine cytidylyltransferase gene (Pcyt2). Mol. Cell. Biol. 2007, 27, 3327-3336.
71. Dobrosotskaya, I.Y.; Seegmiller, A.C.; Brown, M.S.; Goldstein, J.L.; Rawson, R.B. Regulation of SREBP processing and membrane lipid production by phospholipids in drosophila. Science 2002, 296, 879-883.
72. Lim, H.Y.; Wang, W.; Wessells, R.J.; Ocorr, K.; Bodmer, R. Phospholipid homeostasis regulates lipid metabolism and cardiac function through SREBP signaling in drosophila. Genes Dev. 2011, 25, 189-200.
73. Leonardi, R.; Frank, M.W.; Jackson, P.D.; Rock, C.O.; Jackowski, S. Elimination of the CDP-ethanolamine pathway disrupts hepatic lipid homeostasis. J. Biol. Chem. 2009, 284, 27077-27089.
74. Fullerton, M.D.; Hakimuddin, F.; Bonen, A.; Bakovic, M. The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice. J. Biol. Chem. 2009, 284, 25704-25713.
75. Steenbergen, R.; Nanowski, T.S.; Beigneux, A.; Kulinski, A.; Young, S.G.; Vance, J.E. Disruption of the phosphatidylserine decarboxylase gene in mice causes embryonic lethality and mitochondrial defects. J. Biol. Chem. 2005, 280, 40032-40040.
76. Fullerton, M.D.; Bakovic, M. Complementation of the metabolic defect in CTP:phosphoethanolamine cytidylyltransferase (Pcyt2)-deficient primary hepatocytes. Metabolism 2010, 59, 1691-1700.
77. Singh, R.K.; Fullerton, M.D.; Vine, D.; Bakovic, M. Mechanism of hypertriglyceridemia in CTP:phosphoethanolamine cytidylyltransferase-deficient mice. J. Lipid Res. 2012, 53, 1811-1822.
78. Hussain, M.M.; Rava, P.; Walsh, M.; Rana, M.; Iqbal, J. Multiple functions of microsomal triglyceride transfer protein. Nutr. Metab. (Lond) 2012, 9, 1-16.
79. Wen, H.; Gris, D.; Lei, Y.; Jha, S.; Zhang, L.; Huang, M.T.; Brickey, W.J.; Ting, J.P. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011, 12, 408-415.
80. Jotwani, A.; Richerson, D.; Motta, I.; Julca-Zevallos, O.; Melia, T. Approaches to the study of Atg8-mediated membrane dynamics in vitro. Methods Cell Biol. 2012, 108, 93-116.
81. Li, L.; Chen, Y.; Gibson, S.B. Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation. Cell. Signal. 2012, 25, 50-65.
82. Houweling, M.; Klein, W.; Geelen, M.J. Regulation of phosphatidylcholine and phosphatidylethanolamine synthesis in rat hepatocytes by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem. J. 2002, 362, 97-104.
83. Leick, L.; Fentz, J.; Bienso, R.S.; Knudsen, J.G.; Jeppesen, J.; Kiens, B.; Wojtaszewski, J.F.; Pilegaard, H. PGC-1{α} is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E456-E465.
84. Erickson, K.A.; Smith, M.E.; Anthonymuthu, T.S.; Evanson, M.J.; Brassfield, E.S.; Hodson, A.E.; Bressler, M.A.; Tucker, B.J.; Thatcher, M.O.; Prince, J.T.; et al. AICAR inhibits ceramide biosynthesis in skeletal muscle. Diabetol. Metab. Syndr. 2012, 4, 1-7.
85. Wei, P.; Pan, D.; Mao, C.; Wang, Y.X. RNF34 is a cold-regulated E3 ubiquitin ligase for PGC-1α and modulates brown fat cell metabolism. Mol. Cell. Biol. 2012, 32, 266-275.
86. Li, Z.; Agellon, L.B.; Vance, D.E. Phosphatidylcholine homeostasis and liver failure. J. Biol. Chem. 2005, 280, 37798-37802.
87. Page, G.L.; Laight, D.; Cummings, M.H. Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease. Int. J. Clin. Pract. 2011, 65, 684-690.
88. Rothig, H.J.; Reinauer, H.; Hollmann, S. Synthesis rate of phospholipids, cytochrome b5 and P450 in thiamine deficient rats following treatment with thiamine. Hoppe Seylers Z. Physiol. Chem. 1972, 353, 1562.
89. Czesny, S.; Dettmers, J.M.; Rinchard, J.; Dabrowski, K. Linking egg thiamine and fatty acid concentrations of lake michigan lake trout with early life stage mortality. J. Aquat. Anim. Health 2009, 21, 262-271.